Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy

NCT ID: NCT06067620

Last Updated: 2024-05-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Robotic right hemicolectomy with intra-corporeal anastomosis may have better short-term recovery outcomes and decreased incidence of incisional hernia when compared to the laparoscopic actual standard of care, for similar safety outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During laparoscopic right hemicolectomy (lapRHC) for cancer or polyp, intra-corporeal anastomosis (ICA) offers better short-term recovery and decreased incidence of incisional hernia (IH) when compared to extra-corporeal anastomosis (ECA). However, because of the technical limitations of laparoscopy, ICA has not gained in wide acceptance and ECA has remained the standard of care. On the contrary, robotics offers improved suturing capacities and facilitates the realization of ICA. Therefore, robotic right hemicolectomy (robRHC) with ICA may have better short-term recovery outcomes and decreased incidence of IH when compared to the laparoscopic actual standard of care. In a randomized controlled trial, we will compare robRHC with ICA with lapRHC with ECA, in terms of recovery of bowel function (time to first passage of faeces). Secondary outcomes will notably include length of stay, incidence of IH, patient-reported esthetical outcomes and safety outcomes (morbidity, mortality, proximal and distal margins, harvested lymph nodes).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Neoplasms Colorectal Neoplasms Malignant Colorectal Neoplasms, Benign Colorectal Cancer Colorectal Polyp Colorectal Adenoma Colorectal Adenocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic right hemicolectomy

Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section (fully minimally invasive right hemicolectomy)

Group Type EXPERIMENTAL

Robotic right hemicolectomy

Intervention Type PROCEDURE

Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section, using the Da Vinci Xi.

Laparoscopic right hemicolectomy

Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline (standard of care)

Group Type ACTIVE_COMPARATOR

Laparoscopic right hemicolectomy

Intervention Type PROCEDURE

Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Robotic right hemicolectomy

Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section, using the Da Vinci Xi.

Intervention Type PROCEDURE

Laparoscopic right hemicolectomy

Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients requiring elective minimally invasive RHC for cT1-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure).

Exclusion Criteria

* Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach)
* Emergency surgery
* Hereditary colorectal cancer
* Inflammatory bowel disease
* Synchronous resection of (an)other organ(s)
* Synchronous surgical procedure (including more extended resection of the lower gastrointestinal tract)
* cT4
* cM+
* History of laparotomy
* Pregnancy
* No anastomosis planned
* Unable to provide informed consent
* No informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Geneva

OTHER

Sponsor Role collaborator

Spital Biel, Switzerland

UNKNOWN

Sponsor Role collaborator

Hôpital Fribourgeois

OTHER

Sponsor Role collaborator

Jeremy Meyer

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeremy Meyer

Principal investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Toso, MD, PhD

Role: STUDY_CHAIR

University Hospitals of Geneva

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeremy Meyer, MD, MD-PhD

Role: CONTACT

+41795533248

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRORHEM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.